Multiple Choice
FISH technology
A) uses recombinant DNA technology.
B) detects hematopathologic chromosomal abnormalities.
C) detects oncogenic chromosomal abnormalities.
D) All of the above.
Correct Answer:
Verified
Correct Answer:
Verified
Q4: Magnetic labeling application uses<br>A)automated DNA sequences.<br>B)DNA probe
Q5: Match the type of enzyme immunoassay (EIA)
Q6: Fluorescent molecules in immunofluorescent techniques are used
Q7: Match the assays and definitions.<br>-Inhibition immunofluorescent assay<br>A)Antibodies
Q8: In a changing clinical environment, the indirect
Q10: An advantage of enzyme immunoassay (EIA) compared
Q11: Match the following emerging technology with the
Q12: Match the assays and definitions.<br>-Direct immunofluorescent assay<br>A)Antibodies
Q13: A fluorescent substance or dye absorbs light
Q14: In fluorescent antibody microscopy using a fluorescent